AstraZeneca Market Cap 2006-2018 | AZN

AstraZeneca market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. AstraZeneca market cap as of April 24, 2019 is $98.07B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $98.074B $22.090B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $373.460B 16.93
Pfizer (PFE) United States $234.364B 13.12
Merck (MRK) United States $201.486B 17.22
Novartis AG (NVS) Switzerland $179.764B 15.53
Eli Lilly (LLY) United States $122.227B 21.22
Novo Nordisk (NVO) Denmark $118.193B 19.12
AbbVie (ABBV) United States $116.045B 9.95
Sanofi (SNY) France $104.035B 12.84
GlaxoSmithKline (GSK) United Kingdom $99.050B 13.01
Bristol-Myers Squibb (BMY) United States $72.907B 11.21